This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
CynergisTek Future Growth
Future criteria checks 2/6
Key information
56.9%
Earnings growth rate
61.0%
EPS growth rate
Healthcare earnings growth | 17.1% |
Revenue growth rate | 21.0% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | n/a |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 28 | N/A | -2 | N/A | 1 |
12/31/2023 | 23 | -4 | -4 | N/A | 1 |
12/31/2022 | 19 | -5 | -5 | N/A | 1 |
6/30/2022 | 17 | -10 | -4 | -3 | N/A |
3/31/2022 | 17 | -2 | -4 | -4 | N/A |
12/31/2021 | 16 | -2 | -3 | -3 | N/A |
9/30/2021 | 17 | -13 | -2 | -2 | N/A |
6/30/2021 | 17 | -15 | -3 | -3 | N/A |
3/31/2021 | 18 | -18 | -3 | -3 | N/A |
12/31/2020 | 19 | -18 | -4 | -4 | N/A |
9/30/2020 | 20 | -7 | -5 | -5 | N/A |
6/30/2020 | 20 | -7 | -4 | -4 | N/A |
3/31/2020 | 21 | -6 | -5 | -5 | N/A |
12/31/2019 | 21 | -5 | -2 | -2 | N/A |
9/30/2019 | 23 | -4 | 1 | 1 | N/A |
6/30/2019 | 23 | -3 | 3 | 4 | N/A |
3/31/2019 | 23 | -4 | 7 | 7 | N/A |
12/31/2018 | 21 | -4 | 6 | 6 | N/A |
9/30/2018 | 33 | -6 | 7 | 7 | N/A |
6/30/2018 | 45 | -4 | 5 | 5 | N/A |
3/31/2018 | 58 | -2 | 4 | 4 | N/A |
12/31/2017 | 72 | 0 | 1 | 1 | N/A |
9/30/2017 | 69 | 5 | 0 | 0 | N/A |
6/30/2017 | 66 | 5 | 0 | 1 | N/A |
3/31/2017 | 64 | 5 | -1 | 0 | N/A |
12/31/2016 | 60 | 5 | 0 | 0 | N/A |
9/30/2016 | 60 | 3 | 1 | 1 | N/A |
6/30/2016 | 61 | 2 | 0 | 0 | N/A |
3/31/2016 | 62 | 1 | N/A | 1 | N/A |
12/31/2015 | 61 | 1 | N/A | 2 | N/A |
9/30/2015 | 57 | 1 | N/A | 1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CTEK is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CTEK is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CTEK is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CTEK's revenue (21% per year) is forecast to grow faster than the US market (7.7% per year).
High Growth Revenue: CTEK's revenue (21% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CTEK's Return on Equity is forecast to be high in 3 years time